PET probes beyond 18F-FDG

被引：3
作者：
Lei Jiang [1 ,2 ]
Yingfeng Tu [2 ]
Hongcheng Shi [1 ]
Zhen Cheng [2 ]
机构：
[1] Department of Nuclear Medicine,Zhongshan Hospital,Fudan University
[2] Molecular Imaging Program at Stanford(MIPS),Department of Radiology,Stanford Cancer Institute,Bio-X Program,Canary Center at Stanford for Cancer Early Detection,Stanford University
来源：
TheJournalofBiomedicalResearch | 2014年 / 28卷 / 06期
关键词：
PET; molecular probes; personalized medicine;
D O I：
暂无
中图分类号：
R816 [各部位及各科疾病的X线诊断与疗法];
学科分类号：
1001 ; 100105 ; 100207 ; 100602 ;
摘要：
During the past several decades,positron emission tomography(PET) has been one of the rapidly growing areas of medical imaging;particularly,its applications in routine oncological practice have been widely recognized.At present,F-fluorodeoxyglucose(F-FDG) is the most broadly used PET probe.However,F-FDG also suffers many limitations.Thus,scientists and clinicians are greatly interested in exploring and developing new PET imaging probes with high affinity and specificity.In this review,we briefly summarize the representative PET probes beyondF-FDG that are available for patients imaging in three major clinical areas(oncology,neurology and cardiology),and we also discuss the feasibility and trends in developing new PET probes for personalized medicine.
引用
收藏
页码：435 / 446
页数：12
相关论文
共 50 条
  • [31] 18F-FDG PET of patients with Hurthle cell carcinoma
    Lowe, VJ
    Mullan, BP
    Hay, ID
    McIver, B
    Kasperbauer, JL
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (09) : 1402 - 1406
  • [32] Relevance of quantification in brain PET studies with 18F-FDG
    Ninerola-Baizan, A.
    Aguiar, P.
    Cabrera-Martin, M. N.
    Vigil, C.
    Gomez-Grande, A.
    Lorenzo, C.
    Rubi, S.
    Sopena, P.
    Camacho, V
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2020, 39 (03): : 184 - 192
  • [33] 18F-FDG PET/CT for the Assessment of Myocardial Sarcoidosis
    Hicham Skali
    Allison R. Schulman
    Sharmila Dorbala
    Current Cardiology Reports, 2013, 15
  • [34] 18F-FDG PET/MRI of Rhinosporidiosis of the Upper Airways
    Cazzador, Diego
    Cecchin, Diego
    Colangeli, Roberta
    Crimi, Filippo
    Emanuelli, Enzo
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (10) : E461 - E462
  • [35] Hepatic brucellosis detected by 18F-FDG PET/CT
    Nariman, Mehraban Jaromi
    Andel, Johannes
    Salaheddin, Jarub
    Bachmayr, Mario
    Pichler, Robert
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2022, 25 (03) : 312 - 314
  • [36] Vanishing Bone Metastases in 18F-FDG PET/CT
    Ainouche, Alida
    Morland, David
    Durot, Carole
    Hoeffel, Christine
    Papathanassiou, Dimitri
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (07) : 559 - 560
  • [37] 18F-FDG PET/CT role in Burkitt lymphoma
    Albano, Domenico
    Bertagna, Francesco
    Giubbini, Raffaele
    CLINICAL AND TRANSLATIONAL IMAGING, 2020, 8 (01) : 39 - 45
  • [38] Hepatic Epithelioid Angiomyolipoma and 18F-FDG PET/CT
    Zhang, Yiqiu
    Li, Beilei
    Hou, Jun
    Yu, Haojun
    Shi, Hongcheng
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (06) : 422 - 424
  • [39] Galactocele, Pitfall for the Evaluation by 18F-FDG PET/CT
    Ceyrat, Quentin
    Ziade, Caroline
    Tlili, Ghoufrane
    Fernandez, Philippe
    Meyer, Marie
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (07) : E237 - E238
  • [40] 18F-FDG PET for staging and monitoring of solitary plasmacytoma
    Adib, S.
    Leleu, X.
    Robu, D.
    Huglo, D.
    Steinling, M.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2010, 34 (02): : 88 - 95
12345